A European study identified 92 clonal mutations in 500 healthy donors over the age of 55; donor CHIP, especially DNMT3A-driven CHIP, was associated with increased incidence of chronic GVHD and decreased incidence of relapse or progression. Here, STUB1 is linked to chronic graft versus host disease.